Login

Journal Image
Current Drug Discovery Technologies
ISSN (Print): 1570-1638
ISSN (Online): 1875-6220
VOLUME: 11
ISSUE: 2
DOI: 10.2174/1570163810666131229130207      Price:  $58









Potent Phosphatidylinositol 3-Kinase Inhibitors and Their Biology

img
Author(s): Mukesh Chandra Joshi, Krishan Kumar and Vikrant Kumar
Pages 113-126 (14)
Abstract:
The Phosphoinositide 3-kinase (PI3k) is an important regulator of intracellular signalling pathways, like cell proliferation, migration, survival, and angiogenesis upon activation by growth factor or receptors. The PI3k’s pathway is frequently up-regulated in human cancers, thus inhibition of PI3k’s is a promising approach for cancer therapy. Many potent PI3k’s inhibitors have been reported so far and few of them are in clinical trial like GDC-0941, BGT-226, AZD-6482 and others are natural products etc.
Keywords:
Clinical trial, glioblastoma cell lines, leukemia and lymphoma cell lines, phosphoinositide 3-kinase, proliferation, tumor inhibitors.
Affiliation:
Department of Chemistry, Motilal Nehru College, University of Delhi, Delhi-110021, India.